Fulton Bank N.A. Increases Position in McKesson Corporation $MCK

Fulton Bank N.A. increased its holdings in McKesson Corporation (NYSE:MCK) by 12.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,054 shares of the company’s stock after acquiring an additional 679 shares during the quarter. Fulton Bank N.A.’s holdings in McKesson were worth $4,966,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Norges Bank purchased a new stake in McKesson during the 2nd quarter worth approximately $1,346,661,000. Alliancebernstein L.P. boosted its stake in shares of McKesson by 150.4% during the 2nd quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock valued at $1,661,956,000 after buying an additional 1,362,386 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of McKesson by 56.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company’s stock valued at $906,109,000 after buying an additional 446,060 shares during the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its position in shares of McKesson by 45.6% during the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 833,780 shares of the company’s stock worth $610,977,000 after buying an additional 261,296 shares in the last quarter. Finally, The Manufacturers Life Insurance Company grew its position in shares of McKesson by 34.1% during the second quarter. The Manufacturers Life Insurance Company now owns 839,690 shares of the company’s stock worth $615,305,000 after buying an additional 213,406 shares in the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insiders Place Their Bets

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Maria Martinez sold 349 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the sale, the director owned 301 shares in the company, valued at $282,900.87. The trade was a 53.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 3,868 shares of company stock worth $3,743,820. 0.08% of the stock is owned by company insiders.

McKesson Trading Down 1.2%

Shares of McKesson stock opened at $888.28 on Monday. The stock has a market capitalization of $108.81 billion, a price-to-earnings ratio of 25.55, a PEG ratio of 1.43 and a beta of 0.38. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00. The business’s 50 day simple moving average is $903.68 and its 200-day simple moving average is $834.50.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the prior year, the business earned $8.03 EPS. The firm’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Sell-side analysts predict that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio is currently 9.43%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on MCK. Zacks Research cut shares of McKesson from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 25th. TD Cowen raised their price objective on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Morgan Stanley reissued an “overweight” rating and issued a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Wall Street Zen raised shares of McKesson from a “hold” rating to a “buy” rating in a research report on Sunday. Finally, Evercore reiterated an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $960.93.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.